MedPath

Combination therapy with tiotopium and indacaterol in patients with COPD

Not Applicable
Conditions
Chronic obstructive pulmonary disease (COPD)
Registration Number
JPRN-UMIN000011958
Lead Sponsor
Hamamatsu University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

History of hypersensitivity to tiotropium and indacaterol Patients with bronchial asthma Patients during acute exacerbation Presence of infectious disease, pneumothorax, and severe heart failure

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes of values in respiratory function tests
Secondary Outcome Measures
NameTimeMethod
QOL, safety
© Copyright 2025. All Rights Reserved by MedPath